Viewing Study NCT05323669


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2026-01-01 @ 8:58 AM
Study NCT ID: NCT05323669
Status: UNKNOWN
Last Update Posted: 2022-04-12
First Post: 2022-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Molecular Profile of Thyroid Nodules
Sponsor: Belarusian State Medical University
Organization:

Study Overview

Official Title: Study of Molecular-genetic Profile of Thyroid Nodules
Status: UNKNOWN
Status Verified Date: 2022-04
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MPTN
Brief Summary: Profiling and comparative analysis of genomic alterations and miRNA expression in benign and malignant thyroid tumors using histological and cytological specimens will be performed. Obtained information is necessary to create a molecular test to refine the cancer risk of cytologically indeterminate thyroid nodules.
Detailed Description: This is an non-randomised retrospective study consisting of 2 parts. Part A. Histological specimens (formalin fixed paraffin embedded) of patients who were operated on for benign and malignant thyroid disorders will undergo molecular testing to create a molecular profile of thyroid nodules characteristic of Belarusian population.

Part B. Fixed cytological smears of indeterminate thyroid nodules (categories III, IV and V according to Bethesda scoring system) of operated patients will undergo molecular testing to evaluate the possibility and reliability of molecular testing of fixed cytological smears using available assays.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: